Shuichi Tatarano

19PUBLICATIONS
71CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer geneticsPredictive and prognostic markersMedical robotics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Aug 14, 2026
Sequential Enzalutamide-Docetaxel Versus Abiraterone-Docetaxel Therapy in Castration-Resistant Prostate Cancer: A Subanalysis of the ENABLE Study.

|Jul 21, 2026
Consensus-Based Development of a Surgical Checklist for Transurethral Resection of Bladder Tumor: An Initiative of the Japanese Society of Urologic Oncology.

|Jul 18, 2026
NTRK fusion in metastatic castration-resistant prostate cancer treated with entrectinib: a case report.

|Jul 15, 2026
Evaluation of differences in presentation and postoperative outcomes after adrenalectomy for pheochromocytoma according to age.

|Jul 02, 2026
The Lowest PSA Level Achieved Before CRPC Predicts Abiraterone Response But Not Enzalutamide Response in Metastatic CRPC.

|May 20, 2026
Efficacy and Safety of Enzalutamide and Abiraterone in CRPC Patients With a History of Other Cancers: A Sub-Analysis of the ENABLE Study for PCa.

Pageof 4

Frequent Collaborators

4 joint publications

Hideki Enokida

3 joint publications

Kohei Hashimoto

3 joint publications

Hirofumi Yoshino

3 joint publications

Seiji Hoshi